The pharmaceutical company Affymax just got $10 million for moving forward with an anemia treatment that would require one injection a month as opposed to as many as several shots a week. Imagine the ...

a In all studies hemoglobin response is defined as hematocrit increase of 6% from baseline, independent of transfusion. EPO, erythropoietin; Hb, hemoglobin; s.c., subcutaneous; t.i.w., three times a ...

Many patients with a chronic disease or cancer have to contend with anemia. At present, the hormone EPO is administered to a large number of these patients to alleviate the anemia. But unfortunately, ...

SAN FRANCISCO--(BUSINESS WIRE)--FibroGen, Inc., today announced proof-of-principle for oral anemia therapy FG-4592, a hypoxia-inducible factor (HIF) prolyl hydroxylase inhibitor (PHI), in end-stage ...

A biotech drug widely used to combat chemotherapy-induced anemia in cancer patients may actually be counterproductive, helping cancer cells survive, say researchers from Childrens Hospital Los Angeles ...

Intravenous iron and erythropoietin produced a similar hemoglobin response among hemodialysis patients with moderate anemia. NEW ORLEANS—Intravenous (IV) iron and erythropoietin are equally effective ...

EPO, an important drug for treating anemia, can now be produced in higher quantities and with better quality in mammalian cells designed using CRISPR. To many people, EPO rhymes with doping and ...

Source: Getty Images Addressing anemia in CKD requires a proactive, multifaceted approach, incorporating both conventional and nutritional strategies. Early recognition and intervention are essential ...

Iron-deficiency anemia is a common complication of chronic kidney disease (CKD). It happens when your body doesn't have enough iron. You need iron to make the protein hemoglobin, which helps your red ...

Anemia is a common comorbidity in children with chronic kidney disease (CKD). This condition is associated with multiple adverse clinical consequences and its management is a core component of ...

Eugene Goldwasser, a largely unsung biochemist whose 20-year pursuit of an elusive protein led to the development of a widely used anemia drug that became one of the biggest products of the ...

In the first study, published by Henke and co-workers, 351 patients undergoing radiotherapy for head and neck cancer were randomized to receive epoetin beta or placebo, given in parallel with ...